{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-23-000011","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2023-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.623899+00:00","generated_at":"2026-06-19T23:43:09.380451+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetMed Express reports Q3 net loss of $19K; revenue down 3% to $58.9M; declares $0.30 dividend","bullets":["Net sales $58.9M (down 3% YoY); net loss $19K vs net income $4.3M prior year.","Adjusted diluted EPS $0.02; Adjusted EBITDA $2.7M, down 64% from $7.6M.","New customers increased 9% YoY, first increase in 10 quarters.","Board declares $0.30 per share quarterly dividend, payable Feb 27, 2023 to holders of record Feb 20.","Evaluating sales tax contingencies that could have material effect on results."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-23-000011","json":"https://secwatch.observer/filing/0001040130-23-000011.json","markdown":"https://secwatch.observer/filing/0001040130-23-000011.md","text":"https://secwatch.observer/filing/0001040130-23-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/0001040130-23-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/pets-20230206.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T23:43:09.380451+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e01425275443a9eb38875ff3e796e54649c99b8e","claim":"PETMED EXPRESS INC reported third quarter ended December 31, 2022 results: revenue $58.9 million, net income $19.0 thousand, EPS $(0.00) diluted earnings per share.","evidence_excerpt":"Expert TM , today announced its financial results for its third quarter ended December 31, 2022. Quarterly Highlights • Net sales for the quarter ended December 31, 2022, were $58.9 million, compared to $60.7 million for third quarter in the prior year, a decrease of 3.0%. • PetMeds® reports new customers increased 9% year over year for the quarter ended December","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013023000011/0001040130-23-000011-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended December 31, 2022"},{"label":"Revenue","value":"$58.9 million"},{"label":"Net income","value":"$19.0 thousand"},{"label":"EPS","value":"$(0.00) diluted earnings per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}